4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050256
Chief Executive Officer sold 7,800 shares at an average $39.35 ($306,923)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-06 | Sale | −2,780 | $38.45 | $106,891 | 71,498 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-06 | Sale | −1,120 | $39.42 | $44,150 | 70,378 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-07 | Sale | −2,073 | $39.74 | $82,381 | 68,305 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-07 | Sale | −1,827 | $40.23 | $73,500 | 66,478 | I |
| Open-market sales · 7,800 sh · avg $39.35 · $306,923 | |||||||
Loading xslF345X03/doc4.xml…